Item 2 of Schedule 13D is hereby amended to add the following: In connection with the withdrawal of BHW's director nominees for election at the Issuer's 2025 annual meeting of stockholders (the "Annual Meeting"), Kathleen Ann Scheffer, Charles C. Alfiero, Michael W. Dolpp and Christine R. Marlow are no longer members of the Section 13(d) group and shall cease to be Reporting Persons immediately upon the filing of this Amendment No. 6 to the Schedule 13D, at which time the Group Agreement, described in Item 6, is also terminated. The remaining Reporting Persons will continue filing statements on Schedule 13D with respect to their beneficial ownership of securities of the Issuer to the extent required by applicable law. Each of the remaining Reporting Persons is party to the Joint Filing Agreement, as further described in Item 6 below.

Item 6 is hereby amended to add the following: On May 22, 2025, issued a press release advising of BHW's notice of withdrawal of its slate of directors for nomination to the Board at the Annual Meeting (the "Withdrawal Notice") notifying the Issuer that it withdrew its nomination of Paul L. Snyder III, Charles C. Alfiero, Michael W. Dolpp and Christine R. Marlow for election to the Board at the Annual Meeting. On May 22, 2025, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons who will remain Reporting Persons subsequent to this Amendment No. 6 agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. The Joint Filing Agreement is attached hereto as Exhibit 99.6 and is incorporated herein by reference.

Item 7 of Schedule 13D is hereby amended to add the following: The following items are filed as exhibits: Exhibit 99.5 Press Release, dated May 22, 2025 Exhibit 99.6 Joint Filing Agreement, dated May 22, 2025